Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization

Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3350/CMH.2018.0072
P932PMC publication ID6435972
P698PubMed publication ID30813680

P2093author name stringTeerha Piratvisuth
Teeravut Tubtawee
Keerati Hongsakul
Kittipitch Bannangkoon
P2860cites workGlobal cancer statistics, 2012Q27860501
Management of hepatocellular carcinoma: An updateQ27860530
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialQ29617955
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaQ29617957
Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot studyQ34293931
The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Q36256535
Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT imagesQ37867877
Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.Q40095261
Clinical utility and limitations of tumor-feeder detection software for liver cancer embolizationQ40116136
Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomographyQ40118448
Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolizationQ40855032
Evaluation of hepatectomy in small hepatocellular carcinoma--comparison with transcatheter arterial embolization therapyQ44492754
Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization.Q50876461
Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: a retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma.Q53324844
Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic MalignancyQ59884573
Rate and Predictive Factors for Sustained Complete Response after Selective Transarterial Chemoembolization (TACE) in Patients with Hepatocellular CarcinomaQ64905777
Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinomaQ68482810
Hepatic artery embolization in 120 patients with unresectable hepatomaQ70150850
Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcatheter arterial embolizationQ71067319
Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patientsQ71627889
Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oilQ80006694
Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinomaQ81094526
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular carcinomaQ1148337
local neoplasm recurrenceQ54945651
P304page(s)74-85
P577publication date2019-03-01
P1433published inClinical and molecular hepatologyQ26853927
P1476titleSafety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
P478volume25